Cetyl myristoleate

Tier 3 — weak evidence · Joint · Anti-inflammatory claims

A fatty acid ester discovered in arthritis-resistant mice. A couple of very small human studies reported improved joint function, but trials were poorly designed and industry-funded. Mechanism of action is not well understood. Generally safe, but insufficient evidence to recommend over better-studied options like glucosamine or curcumin.

Dose: 350 mg/day cetyl myristoleate complex for 30 days; very limited human evidence